FTIR microspectroscopic analysis of the effects of certain drugs on oxidative stress and brain protein structure

Biopolymers

Volumn 89, Issue 6, 2008, Pages 548-554

  Carmona, P ^a   Rodriguez Casado A ^a   Alvarez, I ^b   de Miguel, E ^c   Toledano, A ^b  

^a INSTITUTO DE ESTRUCTURA DE LA MATERIA   (Spain)

^b INSTITUTO CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Amphetamines; Amyloid sheet; FTIR microspectroscopy; Nicotine; Rat

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MICROOPTICS; OXIDATIVE STRESS; PROTEINS; PYRIDINE;

ALZHEIMER'S DISEASE; AMPHETAMINES; AMYLOID PROTEINS; BRAIN AREAS; FTIR MICROSPECTROSCOPY; INFRARED MICRO-SPECTROSCOPY; LIPID OXIDATION; LIPID PEROXIDATION; NEURO-DEGENERATIVE DISEASE; NICOTINE; PROTEIN STRUCTURES; RAT; SHEET FORMATION;

OXIDATION;

AMPHETAMINE; AMYLOID BETA PROTEIN; BRAIN PROTEIN; NICOTINE TARTRATE; PEROXIDE; CENTRAL STIMULANT AGENT; GANGLION STIMULATING AGENT; NICOTINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETA SHEET; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG MECHANISM; HIPPOCAMPUS; INFRARED SPECTROSCOPY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN STRUCTURE; RAT; ANIMAL; BRAIN; BRAIN LEVEL; DRUG EFFECT; HUMAN; METABOLISM; PROTEIN SECONDARY STRUCTURE; SPRAGUE DAWLEY RAT;

RATTUS;

ALZHEIMER DISEASE; AMPHETAMINE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; GANGLIONIC STIMULANTS; HUMANS; LIPID PEROXIDATION; MALE; NICOTINE; OXIDATIVE STRESS; PROTEIN STRUCTURE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 44849117038     PISSN: 00063525     EISSN: 10970282     Source Type: Journal    
DOI: 10.1002/bip.20944     Document Type: Article

References (31)

1. Albuquerque, E. X.; Pereira, E. F.; Mike, A.; Eisenberg, H. M.; Maelicke, A.; Alkondon, M. Behav Brain Res 2000, 113, 131-141.
2. Mazurov, A.; Hauser, T.; Miller, C. H. Curr Med Chem 2006, 13, 1567-1584.
3. Iversen, S. D. C R Acad Sci III 1998, 321, 209-215.
4. Levin, E. D.; Simon, B. B. Psychopharmacology 1998, 138, 217-230.
5. Levin, E. D.; McClernon, F. J.; Rezvani, A. H. Psychopharmacology (Berl) 2006, 184, 523-539.
6. Rosato-Siri, M. D.; Cattaneo, A.; Cherubini, E. J Physiol 2006, 576, 361-377.
7. Kihara, T.; Shimohama, S.; Urushitani, M.; Sawada, H.; Kimura, J.; Kume, T.; Maeda, T.; Akaike, A. Ann Neurol 1997, 42, 159-163.
8. Li, Y.; Papke, R. L.; He, Y. L.; Millard, W. J.; Meyer, E. M. Brain Res 1999, 830, 218-225.
9. Brown, R. W.; Kolb, B. Brain Res 2001, 899, 94-100.
10. Jonnala, R. R.; Buccafusco, J. J. J Neurosci Res 2001, 66, 565-572.
11. Hejmadi, M. V.; Dajas-Bailador, F.; Barns, S. M.; Jones, B.; Wonnacott, S. Mol Cell Neurosci 2003, 24, 779-786.
12. Gutala, R.; Wang, J.; Hwang, Y. Y.; Haq, R.; Li, M. D. Brain Res 2006, 1093, 12-19.
13. Turégano, L.; Martínez-Rodríguez, R.; Álvarez, M. I.; Gragera, R. R.; Gómez de Segura, I.; De Miguel, E.; Toledano, A. J Neurosci Res 2001, 64, 626-635.
14. Martínez-Rodríguez, R.; Toledano, A.; Álvarez, M. I.; Turégano, L.; Colman, O.; Rosés, P.; Gómez de Segura, I; De Miguel, E. J Neurosci Res 2003, 73, 708-716.
15. Dani, J. A.; Ji, D.; Zhou, F. M. Neuron 2001, 31, 349-352.
16. Wonnacott, S.; Sidhpura, N.; Balfour, D. J. Curr Opin Pharmacol 2005, 5, 53-59.
17. Carlson, J.; Noguchi, K.; Ellison, G. Brain Res 2001, 906, 127-134.
18. Amharref, N.; Beljebbar, A.; Dukic, S.; Venteo, L.; Schneider, L.; Pluot, M.; Vistelle, R.; Manfait, M. Biochim Biophys Acta 2006, 1758, 892-899.
19. Rodríguez-Casado, A.; Alvarez, I.; Toledano, A.; De Miguel, E.; Carmona, P. Biopolymers 2007, 86, 437-446.
20. ILAR (Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council). Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC, 1996.
21. R D (Real Decreto) 1201/2005. Protección de los animales utilizados para experimentación y otros fines científicos. BOE 2005;252: 34367-34391.
22. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates,4th ed. Academic Press: San Diego, London, 1998.
23. Vacque, V.; Sombret, B.; Huvenne, J. P.; Legrand, P.; Suc, S. Spectrochim Acta A 1997, 53, 55-66.
24. Surewicz, W. K.; Mantsch, H. H. Biochim Biophys Acta 1988, 952, 115-130.
25. Susi, H.; Byler, P. M. Biochem Biophys Res Commun 1983, 115, 391-397.
26. Susi, H.; Byler, D. M. Methods Enzymol 1986, 130, 290-311.
27. Shinall, H.; Song, E. S.; Hersh, L. B. Biochemistry 2005, 44, 15345-15350.
28. Butterfield, D. A. Free Radic Res 2002, 36, 1307-1313.
29. Tabner, B. J.; Turnbull, S.; King, J. E.; Benson, F. E.; El-Agnaf, O. M.; Allsop, D. Free Radic Res 2006, 40, 731-739.
30. Murray, I. V.; Liu, L.; Komatsu, H.; Uryu, K.; Xiao, G.; Lawson, J. A.; Axelsen, P. H. J Biol Chem 2007, 282, 9335-9345.
31. Kovacic, P.; Cooksy, A. L. Med Hypotheses 2005, 64, 357-366.